<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Impact of Emergency Department Probiotic Treatment of Pediatric Gastroenteritis: Randomized Controlled Trial</dc:title><dc:identifier>https://doi.org/10.7939/DVN/10896</dc:identifier><dc:creator>Freedman, Stephen</dc:creator><dc:creator>Farion, Ken</dc:creator><dc:creator>Schuh, Suzanne</dc:creator><dc:creator>Gouin, Serge</dc:creator><dc:creator>Williamson-Urquhart, Sarah</dc:creator><dc:creator>Sherman, Philip</dc:creator><dc:creator>Willan, Andrew</dc:creator><dc:creator>Goeree, Ron</dc:creator><dc:creator>Johnson, David</dc:creator><dc:creator>Black, Karen</dc:creator><dc:creator>Schnadower, David</dc:creator><dc:creator>Gorelick, Marc</dc:creator><dc:publisher>UAL Dataverse</dc:publisher><dc:description>PROGUT is a randomized, placebo-controlled, double-blind, six-center, Canadian, emergency department trial to determine whether the administration of a probiotic agent (Lacidofil) will result in a significantly lower proportion of children developing moderate to severe disease over the subsequent 2 weeks and will not be associated with a significantly greater occurrence of side effects.</dc:description><dc:subject>Medicine, Health and Life Sciences</dc:subject><dc:subject>diarrhea</dc:subject><dc:subject>digestive system diseases</dc:subject><dc:subject>gastrointestinal diseases</dc:subject><dc:subject>emergency departments</dc:subject><dc:subject>probiotics</dc:subject><dc:subject>pediatrics</dc:subject><dc:subject>randomized controlled trial</dc:subject><dc:subject>gastroenteritis</dc:subject><dc:date>2013</dc:date><dc:type>Clinical data; Questionnaire data</dc:type><dc:source>Modified Vesikari Score</dc:source></oai_dc:dc>